CRCL vs NMR

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

CRCL

56.7
AI Score
VS
CRCL Wins

NMR

46.1
AI Score

Investment Advisor Scores

CRCL

57score
Recommendation
HOLD

NMR

46score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CRCL NMR Winner
Revenue 10.45B 2.26B NMR
Net Income -368.00M 329.50M CRCL
Net Margin -3.5% 14.6% CRCL
ROE -1.4% 8.5% CRCL
ROA -0.1% 0.4% CRCL
Total Assets 479.44B 77.73B NMR
Cash 7.16B 1.70B NMR
Free Cash Flow -12.62B 492.54M CRCL

Relative Price Performance (Last 90 Days)

CRCL 1M: -20.4% · 3M: -11.0% NMR 1M: +1.1% · 3M: -3.1%

Current Technical Phase

CRCL

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.7%), weak momentum, RSI 36

RSI (14): 36.1 · Price: $67.12

NMR

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 55

RSI (14): 55.1 · Price: $9.69

Fundamentals Snapshot

Metric CRCL NMR
Market Cap — —
Forward P/E 51.9 13.0
Trailing P/E 39.1 10.9
Revenue (TTM) — —
Revenue Growth 0.2% 0.2%
Gross Margin 0.3% 0.8%
Operating Margin 0.2% 0.2%
EPS 1.66 0.87
Dividend Yield — 0.03%

Frequently Asked Questions

Based on our detailed analysis, CRCL is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.